Some of these proteins have been isolated and, in some cases, have been expressed in host plants.

Thus, EP 0,295,959 demonstrates, in particular, the expression, in a host plant, of the DNA derived from Bertholletia excelsa H.B.K. (brazil nut) encoding at least one subunit of the storage protein called 2S.

Furthermore, WO 9119801 demonstrates the existence of two storage proteins derived from Theobroma cacao, their precursor and their genes encoding these proteins.

However, up until now, no storage protein derived from the coffee bean and no sequence capable of regulating the transcription of these proteins are known. Yet, it would be very useful to have available sequences of such proteins, in particular in order to modify the original production of the storage proteins in the coffee bean. Furthermore, it would also be very useful to have available a sequence capable of regulating the transcription of such proteins, so as to allow, in

particular, the expression, in the coffee bean, of a protein encoded by a gene of interest.

The aim of the present invention is to respond to these needs.

SUMMARY OF THE INVENTION: To this effect, the present invention relates to any DNA derived from the coffee bean, encoding at least 20 consecutive amino acids of the amino acid sequence SEQ ID NO:2.

The present invention relates to any storage protein derived from the coffee bean, having at least 20 consecutive amino acids of the amino acid sequence SEQ ID NO:2.

Another subject of the present invention relates to all or part of the DNA delimited by nucleotides 1 to 2509 of the nucleic sequence SEQ ID NO:3, capable of regulating the transcription of the storage proteins according to the invention, as well as the use of all or part of this DNA to direct the expression of genes of interest in plants, in particular in the coffee tree.

The present invention also relates to the use of all or part of the DNA delimited by nucleotides 33 to 1508 of the nucleic sequence SEQ ID NO: 1 or of its complementary strand, of at least 10 bp, to carry out a PCR or as probe to detect in vitro or to inactivate in vivo a coffee bean gene encoding a storage protein.

Furthermore, the invention relates to any recombinant plant cell capable of expressing a recombinant storage protein according to the invention.

Finally, the present invention relates to any food, cosmetic or pharmaceutical product comprising all or part of the DNA or of the recombinant proteins according to the invention.

The present invention therefore opens the possibility of using all or part of the DNA according to the invention so as to modify the original production of the storage proteins in the coffee bean. It is therefore possible in particular to envisage overexpressing or underexpressing the expression of all or part of the DNA according to the invention in the coffee bean.

DETAILED DESCRIPTION OF THE INVENTION: For the purposes of the present invention, "homologous nucleic sequence" is understood to mean any nucleic sequence differing from the nucleic sequences according to the invention only in the substitution, deletion and/or insertion of a small number of base pairs. In this context, two nucleic sequences which, because of the degeneracy of the genetic code, encode the same protein will be considered in particular as being homologous. Will also be considered as homologous sequence, that which exhibits more than 70% homology with the nucleic sequence according to the invention.

In the latter case, the homology is determined by the ratio between the number of base pairs of a homologous sequence and that of a nucleic sequence according to the invention.

Furthermore, for the purposes of the present invention, homologous nucleic sequence is also understood to mean a sequence which hybridizes under stringent conditions, that is to say any nucleic sequence capable of hybridizing to the nucleic sequences according to the present invention by the Southern-Blot method, so as to avoid aspecific hybridizations or hybridizations which

are not very stable (Sambrook et al. Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Laboratory Press, USA, 1989, chapter 9.31 to 9.51).

Finally, for the purposes of the present invention, "homologous amino acid sequence" is understood to mean any amino acid sequence differing from the amino acid sequences according to the present invention only in the substitution, insertion and/or deletion of at least one amino acid. Will also be considered as homologous sequence, that which exhibits more than 50% homology with the amino acid sequence according to the invention. In the latter case, the homology is determined by the ratio between the number of amino acids of a homologous sequence and that of an amino acid sequence according to the invention.

In the remainder of the description, the sequences SEQ ID NO: refer to the sequences presented in the sequence listing hereinafter. The synthetic oligonucleotides SEQ ID NO: 5 to SEQ ID NO: 18, which are mentioned in the description and presented in the sequence listing hereinafter, are provided by Genset SA, 1 passage Delaunay, 75011 Paris, France.

Storage proteins are present only in the coffee bean and are highly expressed in the endosperm. In the ripe coffee bean, they represent nearly 50% of the total proteins and play a major role in the maturation of the coffee bean. These proteins influence in particular the structure and the density of the coffee bean as well as its amino acid content. They also play a major role in the storage of amino acids for the germination of the bean.

It is possible to isolate the DNA encoding, as well as the DNA regulating the expression of the storage proteins of the coffee bean by carrying out a conventional inverse PCR starting with nucleic primers

derived from the nucleic sequences SEQ ID NO: 1 and SEQ ID NO: 3. Persons skilled in the art are indeed capable of choosing the primers which are most suitable for carrying out this PCR, for example.

To this effect, a DNA encoding at least 20 consecutive amino acids of the amino acid sequence SEQ ID NO: 2 has been isolated from the coffee bean.

Preferably, said DNA encodes at least one protein derived from the coffee bean, chosen from the group comprising the storage protein ap, having the amino acid sequence SEQ ID NO: 2, the cleavage protein a delimited in the amino acid sequence SEQ ID NO: 2 by amino acids 1 to 304, the cleavage protein , delimited in the amino acid sequence SEQ ID NO: 2 by amino acids 305 to 492, or any nucleic sequences homologous to these sequences.

Given the benefit of the present invention, the invention relates to the DNA delimited by nucleotides 33 to 1508 in the nucleic sequence SEQ ID NO: 1 encoding the storage protein a , or any nucleic sequence, homologous to this sequence. In particular, the invention relates to the DNA comprising at least in the nucleic sequence SEQ ID NO: 1 nucleotides 33 to 944 encoding the cleavage protein a and/or nucleotides 945 to 1508 encoding the cleavage protein .

The present invention also relates to the use of all or part of the DNA delimited by nucleotides 33 to 1508 of the nucleic sequence SEQ ID NO: 1 or of its complementary strand, of at least 10 bp as primer to carry out a PCR or as probe to detect in vitro or to modify the expression in vivo of at least one coffee bean gene encoding at least one storage protein.

The DNA according to the present invention may be advantageously used to express at least one recombinant

storage protein, derived from the coffee bean, in a host plant or microorganism. To this effect, it is possible to clone all or part of the nucleic sequence SEQ ID NO: 1 delimited by nucleotides 33 to 1508 into an expression vector downstream of a promoter, or of a promoter and a signal sequence, and upstream of a terminator, while preserving the reading frame, then the said vector may be introduced into a plant, a yeast or bacterium, for example. Specific examples of application are presented hereinafter.

Furthermore, all or part of the DNA delimited by nucleotides 33 to 1508 of nucleic sequence SEQ ID NO: 1 may be advantageously used in the coffee bean in a form which is modified by mutagenesis so as to modify the original production of storage proteins in the coffee bean and thus to modify the organoleptic quality of the coffee bean.

The invention also relates to the storage protein ap, having the amino acid sequence SEQ ID NO: 2, the cleavage protein ce having the sequence delimited by amino acids 1 to 304 of the amino acid sequence SEQ ID NO: 2 and the cleavage protein P having the sequence delimited by amino acids 305 to 492 of the amino acid sequence SEQ ID NO: 2, or any amino acid sequence which is homologous thereto.

The fact that the storage proteins derived from the coffee bean are synthesized into a large precursor, the storage protein ap, which is cleaved into two proteins, the cleavage protein a and the cleavage protein P, has been demonstrated. The cleavage proteins a and P can recombine in a polymerized form through at least one disulphide bridge. Indeed, it has been possible to isolate in the endosperm of the coffee bean polymerized forms of the cleavage proteins a and/or P and/or of their homologous sequences.

To this effect, the present invention also relates to the polymerized form of the recombinant storage proteins a , a and/or , as well as their homologous sequences.

Another subject of the present invention relates to all or part of the DNA delimited by nucleotides 1 to 2509 of the nucleic sequence SEQ ID NO: 3, capable of regulating the expression of the storage protein having the amino acid sequence SEQ ID NO: 2.

The invention also relates to the use of all or part of the DNA delimited by nucleotides 1 to 2509 of the nucleic sequence SEQ. ID NO: 3, to allow the expression, in the coffee bean or in a heterologous plant, of the storage protein a encoded by nucleotides 33 to 1508 of the nucleic sequence SEQ ID NO: 1 or of a protein encoded by a gene of interest.

The DNA delimited by nucleotides 1 to 2509 of the nucleic sequence SEQ ID NO: 3 may be advantageously used by fusing it, completely or partially, with a gene of interest, while preserving the reading frame, and then by cloning the whole into an expression vector which is introduced into coffee, so as to allow the expression of the protein encoded by this gene in the coffee bean.

The invention also covers all the food, cosmetic or pharmaceutical products comprising all or part of the DNA, or of the recombinant proteins according to the invention. Persons skilled in the art are indeed capable, by means of oligonucleotide probes or of appropriate antibodies, of detecting their presence in very low quantities.

The storage proteins derived from the coffee bean, the DNA derived from the coffee bean encoding at least one of these proteins, as well as the DNA capable of

regulating their transcription, according to the present invention, are characterized in greater detail with the aid of biochemical and molecular analyses hereinafter.

I. Identification of the storage proteins of the coffee bean The total proteins are extracted from ripe fruits of Coffea arabica of the Caturra variety.

To do this, the maternal tissues are separated from the coffee beans which are rapidly ground in liquid nitrogen, and which are then reduced to a powder according to the method of Damerval et al.

(Electrophoresis 7, 52-54, 1986). The coffee proteins are then extracted from 10 mg of this powder which is solubilized in 100 ul of solution containing 3% w/v of CHAPS, 8.5 M urea, 0.15% w/v of DTT and 3% v/v of ampholyte support pH 3-10.

The mixture is then centrifuged at 13,000 g for 5 min and the supernatant which contains the total proteins of the coffee beans is recovered.

A one-dimensional electrophoresis is performed on this supernatant on the basis of a pH gradient, using, for example, the Multiphore system (Pharmacia Biotech AB, Björkgatan 30, 75182 Upsula, Sweden). To do this, 50 ul are deposited/electrophoresis gel.

To separate the total proteins according to their molecular weights, a second SDS-PAGE electrophoresis is then performed on the gels derived from the first electrophoresis, using, for example, a Bio-Rad equipment (Bio-Rad Laboratories, 2000 Alfred Nobel Drive, Hercules, California 94547 USA) under standard conditions, according to the Laemmli method (Nature, 277, 680-688, 1970). To do this, the gels derived from

the one-dimensional electrophoresis are equilibrated with 5 ml/gel of Tris buffer containing 6 M urea, 30% v/v of glycerol, 2% w/v of SDS, 2% w/v of DTT and 2.5% w/v of iodoacetamide, they are placed on the gels of the second SDS-PAGE electrophoresis, and the migration of the proteins is carried out in a Bio-Rad equipment at 40 mA and at a temperature of 120C for 9 h, for example.

The gels thus produced are silver stained by the Bjellqvist et al. method (Electrophoresis, 14, 1357- 1365, 1993).

The images are then.analysed with the aid of a scanner (Scanner XRS 12CX, X-Ray Scanner Corporation, 4030 Spencer Street, Torrance, California 90503 USA) and, for example, with the aid of the Bio Image programme (Bio Image, 777 East Eisenhower Parkway, Suite 950, Ann Arbor, Michigan 48108, USA).

The proteins separated by two-dimensional electrophoresis are transferred onto PVDF membranes in a CAPS buffer, with the aid of a Bio-Rad Transblot Cell (Bio-Rad, USA) maintained at 420 mA and at a temperature of 40C for 1 h 30 min, and then they are stained with coomassie blue, according to the instructions of Applied Biosystems (Applied Biosystems Inc., 850 Lincoln Centre Drive, Foster City, California 94404 USA).

After the transfer, the membranes are dried at room temperature, before storing them at -180C in plastic pouches.

Microsequencing of the N-terminal sequences of the protein blots is carried out with the aid of a sequencer of the Beckman LF 3000 type and of the Beckman Gold HPLC system (Beckmann Instruments Inc., 250 Harbor Boulevard Box 3100, Fullerton, California

92634 USA). For that, the protein blots are cut out of the membrane and subjected to trypsin digestion at pH 8.3 in 50 ul of digestion buffer containing 10% v/v of trypsin, 100 mM of Tris HC1, 1% v/v of triton RTX and 10% v/v of acetonitrile.

The peptides are then separated by HPLC in a C18 column (Merk KGAA Frankfurte Strasse 250, 64923 Darmstadt, DE), using a water/acetonitrile gradient containing 0.05% of TFA, the peptide fractions are concentrated and they are rediluted in 30% of acetonitrile and 0.01% of TFA, and they are sequenced as described above.

The two-dimensional electrophoretic profile, under denaturant conditions of the endosperm of ripe C. arabica beans shows 4 groups of proteins which are represented in particular, these proteins having an apparent molecular weight of the order of 70, 56, 32 and 23 kDa.

It can be observed that 2 proteins of the group of proteins at 23 kDa as well as 2 proteins of the group of proteins at 70 kDa have an N-terminal sequence which is identical to the N-terminal sequence of the cleavage protein P.

Furthermore, the fact that 3 proteins of the group of proteins at 32 kDa and 1 protein of the group of proteins at 56 kDa have an N-terminal sequence identical to the N-terminal sequence of the cleavage protein a was demonstrated.

It was also possible to establish 7 internal sequences, of 5 to 15 amino acids, from one of the proteins of 32 kDa.

Moreover, with the aid of the SwissProt databank (Genetics Computer Group Inc., University Research Park, 575 Science Drive, Madison, Wisconsin 53711 USA)

and using the FASTA programme (Pearson and Lipman, Proc. Natl. Acad. Sci. USA, 85, 2444-2448, 1988), it was possible to demonstrate the fact that the N-terminal sequences of the proteins of 23, 32, 56 and 70 kDa and the internal sequences of the protein at 32 kDa have a high homology with the sequences of storage proteins of certain plant species, such as for example glycinins of Glycine max, 12s proteins of Arabidopsis thaliana, cruciferin of Brassica napus, glutelins of Oryza sativa and lls protein of Cucurbita maxima.

In the light of these results, it has been possible to make the following .hypotheses on the structure of the storage proteins derived from the coffee bean.

The group of proteins of 56 kDa represents a large precursor, the mature storage protein a , comprising two domains, the a domain and the p domain.

The two-dimensional electrophoretic profile also demonstrates the existence of the cleavage protein cc, present in several isoforms at 32 kDa and that of the cleavage protein P, present. in several isoforms at 23 kDa. Thus, like the storage protein aP, the cleavage proteins a and P may exist in various isoforms.

Finally, the group of proteins of 70 kDa represents the trimeric form of the cleavage protein P.

Furthermore, the existence of a fragment of the cleavage protein a of 13 kDa has been demonstrated on the two-dimensional electrophoretic profile.

II. Estimation of the quantity of storage proteins contained in the coffee bean and specificity of expression of the storage proteins derived from the coffee bean The quantity of storage proteins contained in the coffee bean is calculated, in per cent, relative to the total integrated intensity of the two-dimensional

electrophoretic profile. To do this, the integrated intensity of the protein blots, representing the storage protein ccP, the cleavage protein cc, the cleavage protein P the trimeric form of the cleavage protein p and the fragment of the cleavage protein a is measured.

It is accepted that the total integrated density of the two-dimensional electrophoretic profile is equivalent to 100%.

A value of 50% of storage proteins contained in the coffee bean is thus obtained.

Moreover, the expression of the storage proteins of the coffee bean in tissues of the coffee bean other than the endosperm is also checked by two-dimensional electrophoresis. It is thus possible to demonstrate the fact that the storage proteins are only synthesized in a large quantity in the endosperm and in a much lower proportion in the embryo of the coffee bean.

III. Isolation and translation in vitro of the polyA+ messengers RNAs from the total RNAs of the coffee bean The total RNAs are extracted from coffee beans harvested from 4 to 40 weeks after flowering.

To do this, the maternal tissues are separated from the coffee beans which are rapidly ground in liquid nitrogen before being reduced to a powder.

This powder is then resuspended in 8 ml of buffer at pH 8 containing 100 mM Tris-HCl, 0.1% w/v of SDS and 0.5% v/v of P-mercaptoethanol, it is homogenized with one volume of phenol saturated with 100 mM Tris-HCl, pH 8, and then centrifuged at 12,000 g for 10 min at 40C, so as to extract the aqueous phase which is centrifuged (i) once with an equivalent volume of phenol, (ii) twice with an equivalent volume of phenol:chloroform

(1:1) and (iii) twice with an equivalent volume of chloroform.

The total nucleic acids are then precipitated for 1 h at -200C by adding to the aqueous phase 1/10 of the volume of 3 M sodium acetate, pH 5.2 and 2.5 volumes of ethanol.

The whole is then centrifuged at 12,000 g for 30 min at 40C and the pellet is taken up in 10 ml of H20, before precipitating the nucleic acids again in the presence of LiCl (2 M final) and ethanol (2.5 volumes).

After centrifugation, the pellet of total RNAs is taken up in 1 ml of H2O and it is digested for 1 h at 370C with DNAse RQ1 (Promega Corporation, 2800 Woods Hollow Road, Madison, Wisconsin 53711 USA), so as to eliminate any trace of DNA, and the total RNAs are then deproteinized by treatment with phenol and with chloroform, before precipitating them in the presence of sodium acetate as described above.

The total RNAs are then taken up in 500 u1 of H20 and they are quantified by spectrophotometric assay at 260 nm. Their quality is analysed by agarose gel electrophoresis in the presence of formaldehyde and by in vitro translation.

To do this, the polyA+ messenger RNAs(mRNA) are then purified from 500 llg of total RNAs using the Oligotex- dT purification system (Qiagen INC., 9600 De Soto Avenue, Chatsworth, California 91311 USA), and the quality of the mRNAs is then evaluated by their capacity to synthesize proteins in vitro. For that, translation experiments are carried out with 1 ug of mRNA in the presence of a rabbit reticulocyte lysate (Promega, USA), and then the proteins thus synthesized are labelled by incorporation of 35S-methionine (Amersham International plc., Amersham Place, Little

Chalfont, Buckinghamshire HP7 9NA, UK). The labelled proteins are then separated by two-dimensional electrophoresis as described above. After fixing in an acetic acid/ethanol mixture (40/10), the gels are incubated in the presence of Amplify (Amersham, UK), they are dried under vacuum and they are exposed at -800C against an autoradiographic film.

On the one hand, the results of the in vitro translations with the mRNAs extracted from beans 4 to 40 weeks old after flowering demonstrate the presence of numerous proteins with molecular weights of between 1 and 100 kDa.

On the other hand, the results of the in vitro translations with the mRNAs extracted from beans harvested between 16 and 30 weeks after flowering demonstrate the presence, in a large quantity, of proteins which correspond to the a form of the storage proteins. On the other hand, no product of translation corresponding in size to the cleavage proteins a and P is observed. This result confirms the hypothesis made above, according to which these two cleavage proteins are effectively derived from the in vivo cleavage of the large a precursor.

To isolate the cDNA for these storage proteins, two libraries were made in the manner described below.

IV. Construction and screening of cDNA libraries The synthesis of cDNA, necessary for the construction of libraries, is carried out according to the recommendations provided in the "Riboclone cDNA synthesis system M-MLV (H-)" kit (Promega, USA), using the mRNA extracted from coffee beans harvested 16 and 30 weeks after flowering. The efficiency of this reaction is monitored by the addition of [alpha-32P]dCTP during the synthesis of the two DNA strands.

After migration on an alkaline agarose gel (Sambrook et al., Molecular Cloning - A Laboratory Manual, 1989), the size of the new synthesized cDNA is estimated to vary from 0.2 to more than 4.3 kb. The quantifications, with the aid of the DNA Dipstick kit (InVitrogen BV, De Schelp 12, 9351 NV Leek, Netherlands), show that about 100 ng of cDNA are synthesized from 1 ug of mRNA.

The new synthesized cDNA(s) are then treated according to the recommendations provided in the RiboClone EcoRI Adaptator Ligation System kit (Promega, USA) and they are ligated into the plasmid pBluescript II SK (+) (Stratagene, 11011 North Torrey Pines Road, la Jolla, California 92037, USA) previously digested with the restriction enzyme EcoRI and dephosphorylated by treatment with calf intestinal alkaline phosphatase.

The whole of this ligature mixture is used to convert the E. coli strain XLl-Blue MRF' (Stratagene, USA). The bacteria containing recombinant vectors are selected on dishes with LB (Luria-Bertani) medium containing 12.5 ul/ml of tetracycline, 20 ug/ml of ampicillin 80 ug/ml of methicillin and in the presence of IPTG and X- Gal (Sambrook et al., 1989). They are then cultured on Petri dishes so as to obtain about 300 clones per dish.

These clones are transferred onto Nylon filter and they are then treated according to the recommendations provided by Boehringer Mannheim (Boehringer Mannheim GmbH, Biochemica, Postfach 310120, Mannheim 31, DE).

Moreover, the sequence from amino acids 325 to 330 of the sequence SEQ ID NO: 2 is chosen in the amino acid sequence of the cleavage protein P because it makes it possible to designate an oligonucleotide probe which is relatively only slightly degenerate, the probe OLIGO 1, having the nucleic sequence SEQ ID NO: 4, which is labelled at its 5' end by the addition of the

digoxigenin radical (Genosys Biotechnologies Inc., 162A Science Park, Milton Road, Cambridge CB4 4BR, UK).

The filters are prehybridized at 650C for 4 h in the hybridization solution defined in the DIG oligonucleotide 3'-end labelling kit protocol (Boehringer Mannheim, DE) and the hybridization is carried out at 370C for 10 h in the presence of the probe OLIGO1 (10 pmol/ml final).

After the hybridization, the filters are washed in the presence of tetramethylammonium chloride according to the protocol defined by Wood et al. (Proc. Natl. Acad.

Sci. USA, 82, 1585-1588, 1985) and then they are subjected to immunological detection in the presence of CSPD (Tropix, 47 Wiggins Avenue, Bedford, Massachusetts 01730 USA) according to the recommendations provided by Boehringer Mannheim (DIG luminescent detection kit).

A positive clone harbouring the recombinant vector, called "pCSPl" in the remainder of the description, is selected from the screening of the cDNA library carried out 16 weeks after flowering. This vector contains a cDNA, cloned into the EcoRI site of the vector pBluescript II SK (+), which is sequenced according to the "T7 sequencing kit" protocol (Pharmacia, Sweden) in the presence of [alpha-35S]dATP. This cDNA comprises the last 819 nucleotides of the sequence SEQ ID NO: 1 and, consequently, is incapable of encoding the storage protein ap.

To isolate the cDNA encoding the entire storage protein ap, a new nucleic probe, called SO1 in the remainder of the description, is synthesized. To do this, a PCR is carried out (US Patent 4,683,195 and US Patent 4,683,202)using the synthetic oligonucleotide OLIGO 2, having the nucleic sequence SEQ ID NO: 5, and the synthetic olignucleotide OLIGO 3, having the nucleic sequence SEQ ID NO:6.

The PCR reaction is carried out in the presence of 0.1 ng of vector pCSPl, in a final volume of 50 ul containing 50 mM KCl, 10 mM Tris-HCl, pH 8.8, 1.5 mM MgCl2, 0.1 mg/ml gelatin, 0.2 mM of each dNTP, 0.25 uM of each oligonucleotide (OLIGO 2 and OLIGO*3) and 3 units of Taq DNA polymerase (Stratagene, USA). The reaction mixture is covered with 50 p1 of mineral oil and it is incubated for 30 cycles (940C-30 s, 420C- 30 s, 720C-2 min) followed by a final extension at 720C for 7 min. The fragment obtained after amplification is purified on a Microcon 100 cartridge (Amicon INC, 72 Cherry Hill Drive, Beverly, Massachusetts 01915 USA) and 50 ng of this fragment are labelled by random primer extension with 50 uCi of [alpha-2P]dCTP according to the Megaprime kit (Amersham, UK).

Furthermore, the Nylon filters used during the screening with the probe OLIGO 1 are dehybridized by two washes of 15 min at 370C, in the presence of 0.2 N- NaOH-0.1% SDS (w/v) and then prehybridized for 4 h at 650C in a solution containing 6xSSC, lxDenhart (0.2% Ficoll, 0.2% polyvinylpyrrolidone, 0.2% BSA fraction IV) and 50 ug/ml of denatured salmon sperm DNA. They are then hybridized for 10 h at 650C in the same solution with the whole of the labelled probe SO1 and then they are washed for 30 min at 650C three times in the presence, successively, of 2xSSC-0.1% SDS, lxSSC- 0.1% SDS and 0.1xSSC-0.1% SDS.

A positive clone harbouring the recombinant vector, called in the remainder of the description pCSP2 is thus selected from the screening of the cDNA library carried out at 30 weeks after flowering. This vector contains the sequence SEQ ID NO: 1 of 1706 bp, corresponding to the cDNA encoding the entire storage protein ccP, having as amino acid sequence the sequence SEQ ID NO: 2 and a theoretical molecular weight of 54999 Da. A search of the SwissProt databank with the sequence SEQ ID NO: 2 confirms that this coffee protein

belongs to the family of type lls plant storage proteins.

The cleavage site of the precursor is located between amino acids 304 and 305 of the amino acid sequence SEQ ID NO: 2, as has been observed for all the other type lls plant proteins (Borroto and Dure, Plant Mol. Biol.

8, 113-131, 1987). This is also confirmed by the N- terminal sequencing of the cleavage protein P described above. Consequently, the cleavage protein a corresponds to the first 304 amino acids of the amino acid sequence SEQ ID NO: 2, whereas the cleavage protein P corresponds to the last 188 amino acids of this sequence. The theoretical molecular weights of a and are respectively 34125 Da and 20892 Da and are in agreement with those described above under "Identification of the storage proteins of the coffee bean".

The N-terminal sequences of the cleavage proteins cc and P analysed above are found in the amino acid sequence SEQ ID NO: 2 with the exception of a few amino acids.

These differences are probably explained by the existence of several isoforms of these proteins which may differ from each other by a few amino acids (Shirsat, Developmental Regulation of Plant Gene Expression, Grierson Ed., Blackie, Chapman and Hall NY, 153-181, 1991).

V. Expression of the gene encoding the storage protein « during the development of the Coffea arabica bean The expression of the gene encoding the storage protein a in coffee beans harvested at various stages of development (at 9, 12, 16, 30 and 35 weeks after flowering) is monitored.

To do this, 10 ug of total RNAs of these coffee beans are denatured for 15 min at 650C in lxMOPS buffer

(20 mM MOPS, 5 mM sodium acetate, 1 mM EDTA, pH 7) in the presence of formamide (50%) and formaldehyde (0.66 M final).

They are then separated by electrophoresis, for 6 h at 2.5 V/cm, in the presence of lxMOPS buffer, on a 1.2% agarose gel containing 2.2 M formaldehyde as final concentration.

After migration, the RNAs are stained with ethidium bromide (BET) according to Sambrook et al. 1989, which makes it possible to standardize the quantities deposited on a gel from the intensities of fluorescence of the 16S and 23S ribosomal RNAs.

The total RNAs are then transferred and fixed on a positively charged Nylon membrane according to the recommendations provided by Boehringer Mannheim (Boehringer Mannheim, DE). The prehybridization and hybridization are carried out according to the conditions described above in chapter IV.

The mRNAs encoding the storage protein a are completely absent from the beans harvested up to 9 weeks after flowering. They begin to be very weakly detected in the beans harvested at 12 weeks after flowering and are very abundant in the beans harvested between 16 and 30 weeks after flowering, again becoming very weakly represented in the ripe coffee beans (35 weeks after flowering) . In all cases, the probe SO1 hybridizes with only one class of mRNA whose estimated size at around 1.8 kb is close to that of the nucleic sequence SEQ ID NO: 1.

The kinetics of accumulation of the mRNAs is similar to that observed for most of the genes for storage proteins (Shirsat, 1991). According to the tissue examinations made during the maturation of the coffee beans, it is observed that the increase in the quantity

of mRNA between 12 and 16 weeks after flowering occurs at the same time as the absorption of the perisperm by the endosperm. In comparison with the analyses carried out above by two-dimensional electrophoresis, on the accumulation of proteins during the maturation of the bean, a perfect superposition of the kinetics of accumulation of mRNAs with that of the storage proteins is observed. At the mature stage, the persistence of the storage proteins in the absence of their corresponding messenger RNAs is explained by a high stability of these proteins in vivo. According to these observations, and as has been shown in other plant species (Shirsat, 1991) it appears that the expression of the gene encoding the storage protein a is essentially controlled by a promoter, a sequence capable of regulating the transcription of the gene, which is specifically expressed in the endosperm of the coffee beans.

VI. Isolation of the promoter of the gene encoding the storage protein a of Coffea arabica The promoter of the gene encoding the storage protein a of Coffea arabica is isolated by several inverse PCRs according to the method of Ochman et al. (Genetics 120, 621-623, 1988).

To do this, the nuclear DNA of coffee is isolated from young leaves of C.arabica, Caturra variety, according to the protocol described by Rogers and Bendich (Plant Mol. Biol. Manuel, Gelvin, Schilperoort and Verma Eds, Kluwer Academic Publishers Dordrecht, Netherlands, A6, 1-11, 1993).

0.5 to 1 ug of this DNA is digested with several restriction enzymes, such as for example DraI, HincII and NdeI, and then treated with phenol:chloroform (1:1) and it is precipitated for 12 h at -200C in the

presence of sodium acetate 0.3 M final and of ethanol (2.5 volumes) After centrifugation at 10,000 g for 15 min at 40C, the DNA is taken up in about 500 ul of ligation buffer containing 30 mM Tris-HCl, pH 7.8, 10 mM MgCl2, 10 mM DTT and 0.5 mM rATP, so as to obtain a final DNA concentration of about 1 to 2 ng/ul. The ligation is carried out for 12 h at 140C in the presence of T4 DNA ligase at 0.02 Weiss u/ul and then the self-ligated genomic DNA is precipitated as described above and it is taken up in 20 ul of H20 before quantifying it with the DNA Dipstick kit (InVitrogen, Netherlands). a) Inverse PCR reaction No. 1 This first reaction is carried out using the synthetic oligonucleotide S010, having the nucleic sequence SEQ ID NO: 7, and the oligonucleotide SOll, having the nucleic sequence SEQ ID NO: 8.

This inverse PCR reaction is carried out in the presence of 50 ng of ligated genomic DNA in a final volume of 50 ul containing 50 mM KCl, 10 mM Tris-HCl, pH 8.8, 1.5 mM MgCl2, 0.1 mg/ml of gelatin, 0.2 mM of each dNTP, 0.25 uM of each oligonucleotide (S010 and SOll) and 3 units of Taq DNA polymerase (Stratagene, USA). Next the reaction mixture is covered with 50 ul of mineral oil and it is incubated for 30 cycles (940C- 30 s, 560C-30s, 720C-3 min) followed by a final extension cycle at 720C for 7 min.

The amplified DNA fragments are then analysed by molecular hybridization (J. Southern, Mol. Biol. 98, 503-517, 1975), they are separated by electrophoresis on 1% agarose gel stained with ethidium bromide and then they are transferred in the presence of 0.4 N NaOH for 12 h onto positively charge Nylon membrane (Boehringer Mannheim, DE).

After the transfer, the membrane is baked for 15 min at 1200C and then it is prehybridized at 650C for 4 h in the hybridization solution defined in the "DIG oligonucleotide 3'-end labelling kit" protocol (Boehringer Mannheim, DE).

The membrane is then hybridized at 370C for 10 h in the presence of the synthetic oligonucleotide S012 (10 pmol/ml), having the nucleic sequence SEQ ID NO: 9 and labelled at its 5' end with a digoxigenin radical.

After hybridization, the filters are washed in the presence of tetramethylammonium chloride according to the protocol defined by Wood et al., 1985, and then they are subjected to immunological detection in the presence of CSPD (Tropix, USA), according to the recommendations provided in the DIG luminescent detection kit (Boehringer Mannheim, DE).

After autoradiography, the presence of a DNA fragment of about 1.7 kb, derived from the inverse PCR reaction on the genomic DNA initially digested with the restriction enzyme HincII, which binds the probe S012, is detected.

This DNA is then cloned into the vector pCR-Script (SK+) (Stratagene, USA). To do this, 10 ul of the inverse PCR reaction are mixed with 100 pl of sterile water and then the mixture is centrifuged for 10 min at 3000 g in a Microcon 100 cartridge (Amicon, USA).

3 ul of the DNA thus purified are treated in the presence of native Pfu DNA polymerase (Stratagene, USA) in order to convert its cohesive ends to blunt ends.

This reaction is carried out in a final volume of 10 ul containing 10 mM KCl, 6 mM (NH4)2S04, 20 mM Tris-HCl, pH 8.0, 0.1% Triton X-100, 2 mM MgCl2, 1 mM of each dNTP, 10 ug/ml BSA and the reaction mixture is covered

with 50 ul of mineral oil, it is incubated for 30 min at 720C and then 1 ul of this reaction mixture is directly used in the ligation reaction with the vector pCR-Script SK(+).

The whole of this ligation mixture (10 ul) is used to transform the E.coli strain XLl-Blue MRF' (Stratagene, USA). The bacteria containing the recombinant vectors are selected on dishes with LB medium containing 20 ug/ml of ampicillin, 80 ug/ml of methicillin and in the presence of IPTG and X-Gal (Sambrook et al., 1989).

At the end of the transformation, about 100 clones are obtained which are transferred onto Nylon filter and are analysed by molecular colony hybridization (Grunstein and Hogness, Proc. Natl. Acad. Sci. USA 72, 3961-3965, 1975) with the probe S012 according to the conditions described above. This screening makes it possible to isolate a positive clone harbouring the recombinant vector pCSPPl. This vector contains the genomic DNA fragment detected by autoradiography which is cloned into the SfrI site of the vector pCR-Script (SK+). This DNA is sequenced, according to the protocol defined by Pharmacia (T7 sequencing kit), in the presence of [alpha-35S]dATP. It comprises the last 1717 base pairs of the nucleic sequence SEQ ID NO: 3, bordered at each end by an HincII restriction site. It contains 750 base pairs upstream of the codon for initiation of translation of the gene encoding the storage protein a and the first 968 base pairs of this nuclear gene. Given the fact that this gene belongs to a multigene family, it will be called hereinafter CSP1.

This partial sequence of the CSP1 gene shows the presence of two introns of identical size (111 bp) located respectively between nucleotides 2811-2921 for the first, and nucleotides 3239-3349 for the second nucleic sequence SEQ ID NO: 3. These two introns have sizes less than those observed, for example, in

Arabidopsis thaliana but they are on the other hand located at the same positions as those observed in this plant (Pang et al., Plant Mol. Biol 11, 805-820). b) Inverse PCR reaction No. 2: first screening To obtain the nucleic sequences located upstream of the HincII site (position 1763 of the nucleic sequence SEQ ID NO: 3, another inverse PCR reaction is carried out using, this time, the synthetic oligonucleotides S016 and S017 deduced from the sequence previously cloned to the plasmid pCSPPl and having respectively the nucleic sequences SEQ ID NO: 10 and SEQ ID NO: 11.

This inverse PCR reaction is carried out under conditions identical to those described for the inverse PCR reaction No. 1, with the exception of the following parameters: the attachment of the oligonucleotides was carried out at 570C and 35 polymerization cycles were performed.

As defined above, the DNA fragments amplified by this .PCR are analysed by molecular hybridization after having been separated on an electrophoresis gel and they are transferred onto a Nylon membrane. This membrane is then prehybridized for 4 h at 650C in a solution containing 6xSSC, lxDenhart (0.2% Ficoll, 0.2% polyvinylpyrrolidone, 0.2% BSA fraction IV) and 50 ug/ml of denatured salmon sperm DNA and then it is hybridized for 10 h at 650C in the same solution with the probe S01016.

This probe is in fact synthesized by PCR using the synthetic oligonucleotides S010 and S016 described above, in the presence of 0.1 ng of vector pCSPP1, in a final volume of 50 ul containing 50 mM KCl, 10 mM Tris- HCl, pH 8.8, 1.5 mM MgCl2, 0.1 mg/ml gelatin, 0.2 mM of each dNTP, 0.25 AM of each oligonucleotide (S010 and S016) and 3 units of Taq DNA polymerase (Stratagene,

USA). The reaction mixture is covered with 50 ul of mineral oil and it is incubated for 30 cycles (940C- 30 s, 460C-30 s, 720C-2 min) followed by a final extension cycle at 720C for 7 min. The fragment obtained after amplification (698 bp) is purified on a Microcon 100 cartridge (Amicon, USA) and 50 ng of this fragment are labelled by random primer extension with 50 uCi of [alpha-32P]dCTP according to the Megaprime kit (Amersham, UK) protocol.

After hybridization, the membrane is washed three times for 30 min at 650C in the presence, successively, of 2xSSC-0.1% SDS, lxSSC-0.1% SDS and O.lxSSC-O.1 SDS and it is analysed by autoradiography so as to detect a DNA fragment of about 1 kb which binds the probe S01016.

This DNA, derived from the inverse PCR reaction on the genomic DNA initially digested with the restriction enzyme NdeI, is then treated with Pfu DNA polymerase and then it is ligated into the vector pCR-Script(SK+) as described above. This ligation is then used to transform the E.coli strain XLl-Blue MRF' and the transformants are selected and analysed by molecular hybridization with the probe S01016 according to the conditions described above. This screening makes it possible to isolate a positive clone harbouring the vector pCSPP2. As expected, this vector results from the cloning into the SfrI site of the vector pCR-Script (SK+) of the DNA fragment previously identified by hybridization. The latter, which corresponds to the DNA segment between nucleotides 1514 and 2523 of the nucleic sequence SEQ ID NO: 3, bordered at each of the ends by an NdeI restriction site and which consequently contains 250 bp in addition upstream of the genomic DNA fragment cloned into the vector pCSPPl, is sequenced.

c) Inverse PCR reaction No. 2: second screening To clone nucleotides 1 to 1513 of the nucleic sequence SEQ ID NO: 3, another molecular hybridization is performed on the DNA fragments derived from the inverse PCR reaction No. 2.

To do this, the probe used, called S01720, is deduced from the sequence of coffee nuclear DNA cloned into the vector pCSPP2 and it is synthesized by PCR using the oligonucleotide S017 described above and the oligonucleotide S020 having the nucleic sequence SEQ ID NO: 12. This reaction is carried out in the presence of 0.1 ng of vector pCSPP2, under conditions identical to those used for the synthesis of the probe S01016, with the exception of the temperature for attachment of the oligonucleotides which is 500C. The fragment obtained after amplification (262 bp) is labelled as described above and it is used as probe to test the inverse PCR reactions No. 2.

The Nylon membrane used during the screening of the products of the inverse POR reaction No. 2 with the probe S01016 is dehybridized by two washes for 15 min at 370C in the presence of 0.2 N NaOH-0.l% SDS (w/v), then it is prehybridized and it is hybridized as described above with the probe S01720.

At the end of this hybridization, a DNA fragment of about 1.9 kb, derived from the inverse PCR reaction No. 2 on the genomic DNA initially digested with the restriction enzyme DraI, is detected. As described above, this DNA is then treated with Pfu DNA polymerase, it is ligated into the vector pCR-Script (SK+) and the entire ligation is used to transform the E.coli strain XLl-Blue MRF'.

The transformants are then selected and they are screened by molecular hybridization with the probe

S01720. It is thus possible to isolate a positive clone harbouring the vector pCSPP3 which results from the cloning into the SfrI site of the vector pCR-Script (SK+) of the DNA fragment previously identified by hybridization. The latter, which corresponds to the DNA segment between nucleotides 1 and 1886 of the nucleic sequence SEQ ID NO: 3, bordered at each end by a DraI restriction site, is sequenced. It therefore contains 1513 base pairs in addition upstream of the genomic DNA fragment cloned into the vector pCSPP2. d) Cloning of the genomic DNA fragments The inverse PCR experiments form chimeric linear molecules by combining noncontiguous DNA fragments in the genome with each other (Ochman et al., 1988).

Moreover, measurements of mutation frequency show that the Pfu DNA polymerase is approximately twelve times more accurate than Taq DNA polymerase, which reduces the probability of point mutations during PCR amplifications (Lundberg et al., Gene 108, 1-6, 1991).

For these reasons, a PCR reaction is carried out on the native genomic DNA of C. arabica, Caturra variety, in the presence of Pfu DNA polymerase. This reaction is carried out in the presence of 10 ng of genomic DNA, in a final volume of 50 ul containing 10 mM KCl, 6 mM (NH4)2SO4, 20 mM Tris-HCl, pH 8.0, 0.1% Triton X-100, 2 mM MgCl2, 10 ug/ml BSA, 0.2 mM of each dNTP, 0.25 uM of the oligonucleotides, S010 and S020 described above and 3 units of Pfu DNA polymerase. The oligonucleotide S010 is located on the antisense strand of the nucleic sequence SEQ ID NO: 3, between nucleotides 2512 and 2534 whereas the oligonucleotide S020 is located on the sense strand of the nucleic sequence SEQ ID NO: 3, between nucleotides 1565 and 1584. The reaction mixture is then covered with 50 ul of mineral oil and it is incubated for 45 cycles (940C-30 s, 500C-30 s, 720C-

3 min) followed by a final extension cycle at 720C for 7 min.

Following this PCR, a single fragment is obtained which is cloned into the vector pCR-Script (SK+) to give the vector pCSPP4. By sequencing, it is shown that this genomic DNA fragment corresponds to the sequence between oligonucleotides S010 and 5020. The DNA amplified during this PCR reaction is then used for the construction of the vectors, as described below.

VII. Construction of the genetic transformation vectors necessary for the functional analysis of the promoter of the gene encoding the storage protein a of Coffea arabica The sequences located upstream of the site of initiation of translation, positioned at 2510 of the nucleic sequence SEQ ID NO: 3, are analysed in order to test their capacity for regulating the expression of the reporter gene uidA, in the beans of transformed plants.

To do this, several constructs are made in the binary transformation vector pBI101 (Clontech Laboratories Inc., 1020 East Meadow Circle, Palo Alto, California 94303-4230 USA). This vector contains the reporter gene uidA which encodes P-glucuronidase (GUS) and the bacterial gene nptII, which encodes neomycin phosphotransferase. The latter confers resistance to kanamycin in the transformed plants. These two genes are bordered by the right and left ends of the T-DNA of the plasmid pTiT37 of Agrobacterium tumefaciens (Bevan, Nucl. Acids Res. 12, 8711-8721, 1984) which define the DNA region capable of being transferred into the genome of plants infected with this bacterium.

The vector pBI101 is digested with the restriction enzyme BamHI and it is dephosphorylated by treatment

with calf alkaline phosphatase (Promega, USA) according to the protocol defined by the supplier.

Next, DNA fragments of different size which are obtained by PCR in the presence of the vector pCSPP4, of Pfu DNA polymerase and of two synthetic oligonucleotides each containing at their 5' end the nucleic sequence SEQ ID NO: 13, are cloned into the vector PBI101. This sequence comprises a BamHI restriction site which allows the cloning of the PCR products into the vector pBI101 linearized with the same enzyme.

A synthetic oligonucleotide is used, on the one hand, which is capable of binding to the promoter and, on the other hand, the oligonucleotide BAGUS which has the nucleic sequence SEQ ID NO: 14. The use of the latter allows, after digestion of the PCR products with the restriction enzyme BamHI, a translational fusion between the first 5 amino acids of the storage protein ccP of the coffee bean and the N-terminal end of P- glucuronidase to be obtained. a) Construction of pCSPP5 The PCR reaction is carried out with 5 ng of plasmid pCSPP4, in a volume of 50 ul containing 10 mM KCl, 6 mM (NH4)2S04, 20 mM Tris-HCl, pH 8, 0.1% Triton X-100, 2 mM MgCl2, 0.2 mM of each dNTP, 10 ug/ml BSA, 0.25 uM of the oligonucleotide UP210 having the nucleic sequence SEQ ID NO: 15 and BAGUS, having the nucleic sequence SEQ ID NO: 14, and 3 units of Pfu DNA polymerase. The reaction mixture is covered with 50 ul of mineral oil and it is incubated for 30 cycles (940C-30 s, 550C- 30 s, 720C-2 min) followed by a final extension cycle at 720C for 7 min.

The PCR fragment of about 950 bp is purified on a Microcon 100 cartridge (Amicon, USA), and it is

digested for 12 h at 370C with BamHI (Promega, USA) and it is ligated into the linearized vector pBI101, in the presence of T4 DNA ligase (Promega, USA), according to the recommendations provided by the supplier. Next, the E. coli strain XLl-Blue MRF' is transformed with the entire ligation mixture. The plasmids are independently extracted from several transformants and they are sequenced so as to determine the orientation of the PCR fragment in the binary vector. This analysis thus makes it possible to select the plasmid pCSPP5. b) Construction of pCSPP6 The construction of this vector is carried out as described for the vector pCSPP5 except for the fact that the oligonucleotide UP210 is replaced with the oligonucleotide UP211 which has the nucleic sequence SEQ ID NO: 16. The cloning of the PCR product (about 700 bp), correctly oriented in the vector pBI101, gives the vector pCSPP6. c) Construction of pCSPP7 The construction of this vector is carried out as described for the vector pCSPP5 except for the fact that the oligonucleotide UP210 is replaced with the oligonucleotide UP212 which has the nucleic sequence SEQ ID NO: 17. The cloning of the PCR product (450 bp), correctly oriented in the vector pBI101, gives the vector pCSPP7. d) Construction of pCSPP8 The construction of this vector is carried out as described for the vector pCSPP5 except for the fact that the oligonucleotide UP210 is replaced with the oligonucleotide UP213 which has the nucleic sequence SEQ ID NO: 18. The cloning of the PCR product (250 bp),

correctly oriented in the vector pBI101, gives the vector pCSPP8.

VIII. Transformation of Agrobacterium tumefaciens The vectors described above (pCSPP5-8), as well as the plasmids pBI101 and pBI121 (Clontech) are independently introduced into the disarmed Agrobacterium tumefaciens strain C58pMP910 (Koncz and Schell, Mol. Gen. Genet.

204, 383-396, 1986) according to the direct transformation method described by An et al. (Plant Mol. Biol. Manuel, Gelvin, Schilperoort and Verma Eds, Kluwer Academic Publishers Dordrecht, Netherlands, A3, 1-19, 1993) . For teach transformation, the recombinant Agrobacterium tumefaciens clones are selected on LB medium supplemented with kanamycin (50 ug/ml) and rifampicin (50 ug/ml).

To check the structure of the plasmids introduced into Agrobacterium tumefaciens, they are extracted by the rapid minipreparation technique described by An et al.

(1993) and they are analysed by restriction mapping after reverse transformation in the E.coli strain XL1- Blue MRF'.

In the plasmid pBI101, the gene uidA is silent because it lacks a promoter. In contrast, this same gene is expressed in plants transformed with the vector pBI121 because it is under the control of the constitutive CaMV 35S promoter (Jefferson et al., J. EMBO, 6, 3901- 3907, 1987). These two plasmids were used respectively as negative and positive controls for the expression of the reporter gene uidA.

IX. Transformation and regeneration of Nicotiana tabacum The transformation of Nicotiana tabacum var. XHFD8 is carried out with the vectors described above (pCSPP5-8,

pBI101 and pBI121), according to the protocol described by Horsch et al. (Plant Mol. Biol. Manuel, Gelvin, Schilperoort and Verma Eds, Kluwer Academic Publishers Dordrecht, Netherlands, A5, 1-9, 1993).

To do this, foliar discs of plantlets which are germinated in vitro are incubated for about 2 min with a transformed stationary phase culture of Agrobacterium tumefaciens diluted in a 0.9% NaCl solution so as to obtain an OD measurement at 600 nm of between 0.2 and 0.3. They are then dried on 3 MM paper (Whatmann), they are incubated, without selection pressure, in a culture chamber on MS-stem medium (MS salts 4.3 g/l, sucrose 30 g/l, agar 8 g/l, myoinositol 100 mg/l, thiamine 10 mg/l, nicotinic acid 1 mg/l, pyridoxine 1 mg/l, naphthaleneacetic acid (NAA) 0.1 mg/l, benzyladenine (BA) 1 mg/l) (Murashige and Skoog, Physiol. Plant 15, 473-497, 1962).

After 3 days, the discs are transferred onto MS medium supplemented with kanamycin (100 ug/ml) and with cefotaxime (400 ug/ml) in order to multiply the transformed cells so as to obtain calli. These discs are then subcultured every week on fresh "MS-stem" medium.

After 21 to 28 days, the buds which germinate are cut from the calli and they are subcultured on standard MS medium, that is to say an MS medium free of phytohormones, supplemented with kanamycin (100 ,ug/ml) and with cefotaxime (200 ug/ml). After rooting on a Petri dish, the plantlets are transplanted into earthenware pots in a substrate composed of peat and compost and then grown in a greenhouse at a temperature of 250C and with a photoperiod of 16 h. For each transformation experiment, 30 plantlets (R0 generation) are selected. All these plantlets proved to be morphologically normal and fertile. They were selfed and gave seeds (R1 generation).

X. Analysis of the genomic DNA of tobacco plants transformed with Agrobacterium tumefaciens The genomic DNA of transgenic tobacco plants is extracted from the leaves according to the protocol described by Rogers and Bendich (Plant Mol. Biol.

Manuel, Gelvin, Schilpoort and Verma Eds, Kluwer Academic Publishers Dordrecht, Netherlands, A6, 1-11, 1993) and then they are analysed by PCR and by molecular hybridization, according to the Southern-Blot technique.

The PCR reactions are carried out with 10 ng of DNA in a final volume of 50 ul containing 50 mM KC1, 10 mM Tris-HCl, pH 8.8, 1.5 mM MgCl2, 0.1 mg/ml gelatin, 0.2 mM of each dNTP, 3 units of Taq DNA polymerase, 0.25 uM of the oligonucleotide BI104, having the sequence SEQ ID NO: 19 described in the sequence listing hereinafter, and 0.25 AM of the oligonucleotide BI105, having the sequence SEQ ID NO: 20, described in the sequence listing hereinafter. The oligonucleotide BI104 is located at 27 bp downstream of the BamHI site of the plasmid BI101 and the oligonucleotide BI1OS is located at 73 bp upstream of the BamHI site of the plasmid pBI101. The PCR reactions are carried out over 30 cycles (940C-30 s, 540C-30 s, 720C-2 min) followed by a cycle of 7 min at 720C (final extension).

The DNA fragments amplified from transgenic tobacco plants transformed with the plasmids pBI101 (negative control), pBI121 (positive control), pCSPP5, pCSPP6, pCSPP7 and pCSPP8 have molecular weights of about 280 bp, 1030 bp, 1230 bp, 980 bp, 730 bp and 430 bp respectively. In all cases, it is concluded that the fragment initially cloned upstream of the reporter gene uidA is intact.

10 ug of the DNA from tobacco plants transformed with Agrobacterium tumefaciens are digested with BamHI.

Next, the restriction fragments obtained are separated

by electrophoresis on agarose gel (1%) and the DNA is transferred onto a Nylon filter, before hybridizing it independently with a probe uidA and a probe nptII.

The probe uidA is synthesized by PCR using the synthetic olignucleotide GMP1, having the sequence SEQ ID NO: 21 described in the sequence listing hereinafter, and the synthetic oligonucleotide GMP2 having the sequence SEQ ID NO: 22 described in the sequence listing hereinafter, in the presence of 0.1 ng of vector pBI101, in a final volume of 50 ul containing 50 mM KCl, 10 mM Tris-HCl, pH 8.8, 1.5 mM MgCl2, 0.1 mg/ml gelatin, 0.2 mM of each dNTP, 0.25 AM of each oligonucleotide and 3 units of Taq DNA polymerase (Stratagene, USA). The reaction mixture is covered with 50 ul of mineral oil and it is incubated for 30 cycles (940C-30 s, 460C-30 s, 720C-2 min) followed by a cycle at 720C for 7 min.

The probe nptII is synthesized by PCR using the synthetic oligonucleotide NPTII-1, having the sequence SEQ ID NO: 23 described in the sequence listing hereinafter, and the synthetic olignucleotide NPTII-2 having the sequence SEQ ID NO: 24 described in the sequence listing hereinafter, in the presence of 0.1 ng of vector pBI101, in a final volume of 50 ul containing 50 mM KCl, 10 mM Tris-HCl, pH 8.8, 1.5 mM MgCl2, 0.1 mg/ml gelatin, 0.2 mM of each dNTP, 0.25 uM of each oligonucleotide and 3 units of Taq DNA polymerase (Stratagene, USA). The reaction mixture is covered with 50 ul of mineral oil and it is incubated for 30 cycles (940C-30 s, 460C-30 s, 720C-2 min) followed by a cycle at 720C for 7 min.

These two probes are purified and then they are labelled as described above in test VI.

The hybridization profiles obtained for each probe are then compared so as to select the tobacco plants transformed with Agrobacterium tumefaciens which have integrated into their genome a single non-rearranged

copy of the T-DNA. The selection of these plants is also confirmed by the results of the analysis of the segregation of the kanamycin-resistance character, after germination in vitro on standard MS medium of the R1 seeds of these plants. Indeed, in this case, a 3/4- 1/4 segregation of the kanamycin-resistance character is observed, which is compatible with the integration of the T-DNA at a single locus of the nuclear DNA.

XI. Study of the functioning characteristics of the coffee promoter and of its derivatives in transgenic tobacco plants This study is carried out on R0 generation plants and on R1 generation mature seeds.

The measurements of the GUS activity are therefore carried out on the leaves and the seeds according to the method described by Jefferson et al. (1987), using MUG (methyl umbelliferyl glucuronide) as substrate and by measuring, by fluorimetry, the appearance of MU (methylumbelliferone) . To do this, the foliar explants (10 mg) and the seeds (about 40) are ground in the presence of sterile sand in 300 yl of extraction buffer (50 mM Na2HPO4, pH 7.0, 10 mM EDTA, 10 mM P- mercaptoethanol) . The cellular debris are removed by centrifugation for 15 min at 40C and the soluble proteins in the supernatant are quantified by the Bradford method (Anal. Biochem. 72, 248-254, 1976) according to the protocol defined by Bio-Rad (USA) and using BSA as standard. The measurements of GUS activity are carried out in microtitre plates incubated at 370C, using 1 ug of soluble proteins in 150 ul of reaction buffer (extraction buffer with 1 mM MUG). The measurements of fluorescence, expressed in pmol MU/min/mg of proteins are carried out at an excitation wavelength of 365 nm and an emission wavelength of 455 nm (FluoroskanII, Labsystem).

The results of the measurements of GUS activity which are presented in Figure 1 hereinafter show that no enyzmatic activity is observed in the leaves and the seeds of the plants containing the T-DNA of the plasmid pBI101. For the other transformation experiments, the differences in GUS activities which are observed between each of the transgenic plants transformed with the same genetic construct can be explained by a positional effect which results from the random integration of the T-DNA into the genome (Jones et al., J. EMBO, 4, 2411-2418, 1985). The plants containing the construct pBI121 have a glucuronidase activity of between 1500 and 20,000 pmol of MU/min/mg of proteins.

For these same plants, no significant differences are observed between the measurements of GUS specific activities carried out using the seeds and the leaves.

These observations confirm the constitutive character of the CaMV 35S promoter in plants (Odell et al., Nature 313, 810-812, 1985).

Analysis of the results shows that the GUS activities measured in the leaves of the plants independently containing the T-DNAs of the plasmid constructs pCSPP5, pCSPP6, pCSPP7 and pCSPP8 are zero. On the other hand, the GUS activities measured in the seeds of these same plants, independently containing the T-DNAs of the plasmid constructs pCSPP5, pCSPP6, pCSPP7 and pCSPP8, are respectively 60, 60, 30 and 12 times higher than the average GUS activity measured in the seeds of the plants transformed with the plasmid pBI121. It is also observed that the maximum expression of the uidA gene is obtained with the vectors pCSPP5 and pCSPP6, reaching on average 465 nmol of MU/min/mg of protein.

From this observation, it can be concluded that the DNA fragment between nucleotides 1572 (5' end of the sequence SEQ ID NO: 15) and 1815 (5' end of the sequence SEQ ID NO: 16) of the sequence SEQ ID NO: 3 contains no sequence which is critical in the functioning of the coffee promoter.

The most substantial deletions made in the promoter (corresponding to the vectors pCSPP7 and pCSPP8) have as a consequence a reduction in the level of expression of the uidA reporter gene which is greater, the more substantial the deletion. On the other hand, these deletions do not lead in any case to a loss of the specificity of expression of the promoter since in all the transgenic plants analysed, the uidA reporter gene continues to be specifically expressed in the seeds.

The measurements of the GUS activity show that the coffee DNA sequence between nucleotides 1572 and 2524 of the sequence SEQ ID NO: 3 described in the sequence listing hereinafter effectively contains a promoter which behaves like a very strong promoter in the tobacco seeds compared with the 35S promoter of CaMV.

It is also observed that this same DNA sequence, as well as the deletions derived therefrom contain the information which is necessary and sufficient to direct the expression of the uidA reporter gene in the seeds of the transgenic tobacco plants at a level which is in all cases greater than that conferred by the reference promoter CaMV35S.

XII. Expression of the coffee lls storage protein in Escherichia coli To overexpress and purify the coffee lls protein in Escherichia coli, a PCR amplification of the DNA sequence between nucleotides 108 and 1517 of the sequence SEQ ID NO: 1 is carried out with the aid of the oligonucleotide TAG1, having the sequence SEQ ID NO: 25, and the oligonucleotide TAG2, having the sequence SEQ ID NO: 26. These two sequences are described in the sequence listing hereinafter. These two oligonucleotides make it possible to introduce the unique EcoRI and PstI sites into the coffee sequence amplified by PCR. They also make it possible to amplify the coffee DNA sequence encoding the coffee storage protein but lacking its cellular addressing sequence,

called "signal peptide", which is between amino acids 1 and 26 of the sequence SEQ ID NO: 2. This strategy was followed so as to limit the toxic effects due to an overexpression in Escherichia coli of the proteins which contain very hydrophobic sequences.

This reaction is carried out in the presence of 50 ng of vector pCSP2, in a final volume of 100 ul containing 1.5 units of Pwo DNA polymerase (Boehringer Mannheim), 10 ul of 10X Pwo DNA polymerase buffer (Boehringer Mannheim), 0.1 mM of each dNTP and 2 nM of each olignucleotide, TAG1 and TAG2. The reaction mixture is incubated for 30 cycles (940C-30 s, 400C-60 s, 720C- 2 min) followed by a final extension cycle at 720C for 7 min. 30 ul of the PCR mixture are then digested with the restriction enzymes EcoRI and PstI according to the recommendations provided by Promega (USA).

The coffee DNA fragment (1400 bp) amplified by PCR is separated by electrophoresis on a 0.88 agarose gel and it is purified according to the recommendations provided in the QIAquick Gel Extraction kit (Qiagen Inc, 9600 De Soto Avenue, Chatsworth, CA91311, USA). It is then ligated into the expression vector pQE31 (Qiagen, USA) previously digested with the enzymes EcoRI and PstI and dephosphorylated by a calf intestinal alkaline phosphatase treatment. The use of the expression vector pQE31 makes it possible to introduce 6 histidines (6 His tag) in phase with the N- terminal end of the coffee lls storage protein, which then facilitates the purification of this recombinant protein after passing over a column of Ni-NTA resin containing Ni2+ ions (Hochuli et al., J. Chromatography, 411, 177-184, 1987).

The ligation mixture is used to transform competent cells of the strain M15[pREP4] of Escherichia coli according to the recommendations provided by Qiagen (USA) and the recombinant bacteria are selected on dishes with LB medium containing 25 ug/ml of kanamycin and 100 ug/ml of ampicillin.

To test the expression of the coffee lls storage protein in Escherichia coli, the bacteria are then cultured in 50 ml of liquid LB medium supplemented with the antibiotics as indicated above until an OD at 600 nm = 1 is obtained. The induction is carried out by adding IPTG to a final concentration of 1 mM into the culture medium and culture samples are collected every 30 minutes. The bacteria are lysed and the soluble proteins are extracted from Escherichia coli under denaturing conditions. These proteins are then separated on a column of Ni-NTA resin following the protocol defined by QIAGEN (QIAexpress system). The protein fractions successively eluted are then analysed by SDS-PAGE electrophoresis. It is thus shown that the only protein capable of binding to the Ni-NTA column corresponds to the coffee lls recombinant protein. This protein is expressed in Escherichia coli with an approximate molecular weight of 55 kDa which is in agreement with that observed in coffee beans for the storage protein in its precursor form, and this taking into consideration the protein sequence modifications which were carried out during the construction of the expression vector.

SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (A) NAME: SOCIETE DES PRODUITS NESTLE (B) STREET: AVENUE NESTLE 55 (C) CITY: VEVEY (D) STATE OR PROVINCE: VAUD (E) COUNTRY: SWITZERLAND (F) POSTAL CODE: 1800 (G) TELEPHONE: 021/924 34 20 (H) TELEFAX: 021/924 28 80 (ii) TITLE OF THE INVENTION: COFFEE PROTEINS (iii) NUMBER OF SEQUENCES: 26 (iv) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: PatentIn Release #1.0, Version #1.30 (EPO) (2) INFORMATION FOR SEQ ID NO: 1: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1706 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: cDNA (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 33..1508 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: AAACACACTA CACTCTCCTC TGTTGTCAGA GA ATG GCT CAC TCT CAT ATG ATT 53 Met Ala His Ser His Met Ile 1 5 TCT CTT TCC TTG TAC GUT CTT TTG TTC CTC GGC TGT TTG GCT CAA CTA 101 Ser Leu Ser Leu Tyr Val Leu Leu Phe Leu Gly Cys Leu Ala Gln Leu 10 15 20 GGG AGA C=A CAG CCA AGG CTC AGG GGT AAA ACT CAG TGC GAT ATT CAG 149 Gly Arg Pro Gin Pro Arg Leu Arg Gly Lys Thr Gln Cys Asp Ile Gin 25 30 35 AAG CTT AAT GCA CAA GAA CCA TCC TTC AGG TTC CCA TCA GAG GCT GOT 197 Lys Leu Asn Ala Gln Glu Pro Ser Phe Arg Phe Pro Ser Glu Ala Gly 40 45 50 55 TTA ACT GAA TTC TGG GAT TCT AAT AAT CCA GAA TTT GGG TGC GCT GGT 245 Leu Thr Glu Phe Trp Asp Ser Asn Asn Pro Glu Phe Gly Cys Ala Gly 60 65 70 GTG GAA TTT GAG CGT AAC ACT GTC CAA CCT AAG GGC CTT CGT TTG CCT 293 Val Glu Phe Glu Arg Asn Thr Val Gln Pro Lys Gly Leu Arg Leu Pro 75 80 85 CAT TAC TCT AAC GTG CCT AAA TTC GTC TAC GTT GTC GAA GGT ACC GGT 341 His Tyr Ser Asn Val Pro Lys Phe Val Tyr Val Val Glu Gly Thr Gly

90 95 100 GTT CAA GGC ACT GTG ATC CCT GGT TGT GCT GAA ACA TTT GAA TCC CAG 189 Val Gln Gly Thr Val Ile Pro Gly Cys Ala Glu Thr Phe Glu Ser Gln 105 110 15 GGT GAA TCA TTT TGG GGT GGT CAG GAA CAG CCG GGC AAA GGG CAA GAA 437 Gly Glu Ser Phe Trp Gly Gly Gln Glu Gln Pro Gly Lys Gly Gln Glu 120 125 130 135 GGC CAA GAG CAA GGT TCC AAA GGT GGT CAG GAA GGG CGA AGG CAA AGG 485 Gly Gln Glu Gln Gly Ser Lys Gly Gly Gln Glu Gly Arg Arg Gln Arg 140 145 150 TTT CCA GAC CGC CAT CAG AAG CTC AGA AGG TTC CAA AAA GGA GAT GTC 533 Pb. Pro Asp Arg His Gin Ly. Leu Arg Arg Phe Gin Ly. Gly Asp Val 155 160 165 CTT ATA TTG CTT CCT GGT TTC ACT CAG TGG ACA TAT AAT GAT GGA GAT 561 Leu Ile Lou Lou Pro Gly Phe Thr Gin Trp Thr Tyr Asn Asp Gly Asp 170 175 180 GTT CCA CTT GTC ACT GTC GCA CTT CTT GAT GTT GCC AAT GAG GCT AAT 629 Val Pro Leu Val Thr Val Ala Leu Leu Asp Val Ala Asn Glu Ala Asn 185 190 195 CAG CTT GAT TTG CAG TCC AGG AAA TTT TTC CTA GCC GGA AAC CCG CAA 677 Gln Leu Asp Leu Gln Ser Arg Lys Phe Phe Leu Ala Gly Asn Pro Gln 200 205 210 215 CAG GGT GGT GGA AAG GAA GGC CAT CAA GGC CAG CAG CAG CAG CAT AGA 725 Gln Gly Gly Gly Lys Glu Gly His Gln Gly Gln Gln Gln Gln His Arg 220 225 230 AAC ATC TTC TCA GGA TTT GAT GAC CAA CTT TTG GCT GAT GCT TTC AAT 773 Asn Ile Phe Ser Gly Phe Asp Asp Gln Leu Leu Ala Asp Ala Phe Asn 235 240 245 GTT GAC CTC AAA ATA ATA CAG AAA TTG AAG GGT CCG AAA GAT CAA AGG 821 Val Asp Leu Lys Ile Ile Gln Lys Leu Lys Gly Pro Lys Asp Gln Arg 250 255 260 GGT AGC ACA GTC CGA GCT GAA AAA CTT CAA CTG TTC CTG CCT GAA TAT 869 Gly Ser Thr Val Arg Ala Glu Lys Leu Gln Leu Phe Leu Pro Glu Tyr 265 270 275 AGT GAG CAA GTG CAA CAA CCC CAA CAA CAG CAG CAG CAG CAA CAA CAT 917 Ser Glu Gln val Gln Gln Pro Gln Gln Gln Gln Glu Gln Gln Gln His 280 285 290 295 GGT GTT GGA AGA GGA TGG AGA TCC AAC GGA CTT GAG GAA ACT TTG TGC 965 Gly Val Gly Arg Gly Trp Arg Ser Asn Gly Lou Glu Glu Thr Leu Cys 300 305 310 ACG GTG AAG CTT AGT GAA AAC ATT GGC CTC GGG CAA GAG GCT GAT GTA 1013 Thr Val Lys Leu Ser Glu Asn Ile Gly Leu Pro Gln Glu Ala Asp Val 315 320 325 TTC AAT CCT CGT GCT GGC CGC ATT ACC ACT GTT AAT AGC CAA AAG ATT 1061 Phe Asn Pro Arg Ala Gly Arg Ile Thr Thr Val Asn Ser Gln Lys Ile 330 335 340 CCT ATC CTC AGC AGC CTC CAA CTT AGT GCA GAA AGA GGA TTC CTC TAC 1109 Pro Ile Leu Ser Ser Leu Gln Leu Ser Ala Glu Arg Gly Phe Leu Tyr 345 350 355 AGC AAT GCC ATT TTT GCA CCA CAC TGG AAT ATC AAT GCA GAT AAT GCC 1157 Ser Asn Ala Ile Phe Ala Pro His Trp Asn Ile Asn Ala His Asn Ala 360 365 370 375 CTG TAT GTG ATT AGA GGA AAT GCA AGA ATT CAG GTG GTG GAT CAC AAA 1205 Leu Tyr Val Ile Arg Gly Asn Ala Arg Ile Gln Val Val Asp His Lys 380 385 390 GGA AAC AAA GTT TTT GAC GAT GAA GTA AAA CAG GGT CAG CTA ATA ATT 1253 Gly Asn Lys Val Phe Asp Asp Gly Val Lys Gln Gly Gln Leu Ile Ile 395 400 405 GTG CCA CAA TAC TTT GCT GTG ATC AAG AAA GCT GGA AAC CAA GGA TTT 1301 Val Pro Gln Tyr Phe Ala Val Ile Lys Lys Ala Gly Asn Gln Gly Phe 410 415 420 GAG TAC GTT GCA TTC AAG ACG AAC GAC AAT GCC ATG ATT AAC CCA CTT 1349 Glu Tyr Val Ala Phe Lys Thr Ann Asp Ann Ala Met Ile Ann Pro Leu 425 430 435 GTT GGA AGA CTT TCG GCA TTT CGA GCA ATT CCT GAG GAA GTT TTG AGG 1397 Val Gly Arg Leu Ser Ala Phe Arg Ala Ile Pro Glu Glu Val Leu Arg 440 445 450 455 AGG TCT TTC CAA ATT TCC AGC GAG GAA GCT GAG GAA TTG AAG TAT GGA 1445 Ser Ser Phe Gln Ile Ser Ser Glu Glu Ala Glu Glu Leu Lys Tyr Gly 460 465 470 AGA CAG GAG CGT TTG CTT TTG AGT GAG CAG TCT CAG CAG GGG AAA AAG 1493 Arg Gln Glu Arg Leu Leu Leu Ser Glu Gln Ser Gln Gln Gly Lys Lys 475 480 485 AGA AGT TGC TTG AGC TAATTATGTA AAAATAATCG TATATTAGTC CATGCATAGT 1548 Arg Ser Cys Leu Ser 490 CTACCAACTA TATGTGTGAA TCTAATTCCA AAATAAAATG GTCAATGGAT GTAAAGACAT 1608 GGCAATCCAA GCCTTACTAC TGGCGTTGAT TGCGAGAAGT TTGATGTTTG GTGACCATGA 1668 GTCAATAATA AACTATGATA ATTAATGTAA AATTTTCC 1706 (2) INFORMATION FOR SEQ ID NO: 2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 492 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: Met Ala His Ser His Met Ile Ser Leu Ser Tyr Val Leu Leu Phe 1 5 10 15 Leu Gly Cys Leu Ala Gln Leu Gly Arg Pro Gln Pro Arg Leu Arg Gly 20 25 30 Lys Thr Gln Cys Asp Ile Gln Lys Leu Asn Ala Gln Glu Pro Ser Phe 35 40 45 Arg Phe Pro Ser Glu Ala Gly Leu THr Glu Phe Trp Asp Ser Asn Asn 50 55 60 Pro Glu Phe Gly Cys Ala Gly Val Glu Phe Glu Arg Asn Thr Val Gln 65 70 75 80 Pro Lys Gly Leu Arg Leu Pro His Tyr Ser Asn Val Pro Lys Phe Val 85 90 95 Tyr Vai Val Glu Gly Thr Gly Val Gln Gly Thr Val Ile Pro Gly Cys 100 105 110 Ala Glu Thr Phe Glu Ser Gln Gly Glu Ser Phe Trp Gly Gly Gln Glu 115 120 125 Gin Pro Gly Lys Gly Gln Glu Gly Gln Glu Gln Gly Ser Lys Gly Gly 130 135 140 Gln Glu Gly Arg Arg Gln Arg Phe Pro Asp Arg His Gln Lys Leu Arg 145 150 155 160 Arg Phe Gln Lys Gly Asp Val Leu Ile Leu Leu Pro Gly Phe Thr Gln 165 70 175 Trp Thr Tyr Asn Asp Gly Asp Val Pro Leu Val Thr Val Ala Leu Leu 180 185 190 Asp Val Ala Asn Glu Ala Asn Gln Leu Asp Leu Gln Ser Arg Lys Phe 195 200 205 Phe Leu Ala Gly Asn Pro Gln Gin Gly Gly Gly Lye Glu Gly His Gln 210 215 220 Gly Gln Gln Gln Gln His Arg Asn Ile Phe Ser Gly Phe asp Asp Gln 225 230 235 240 Leu Leu Ala Asp Ala Phe Asn Val Asp Leu Lys Ile Ile Gln Lys Leu 245 250 255 Lys Gly Pro Lys Asp Gln Arg Gly Ser Thr Val Arg Ala Glu Lys Leu 260 265 270 Gin Leu Pb. Lou Pro Giu Tyr Ser Giu Gln Val Gin Gin Pro Gin Gin 275 280 285 Gln Gln Glu Gln Gln Gln His Gly Val Gly Arg Gly Trp Arg Ser Asn 290 295 300 Gly Leu Glu Glu Thr Leu Cys Thr Val Lys Leu Ser Glu Asn Ile Gly 305 310 315 320 Leu Pro Gln Glu Ala Asp Val Phe Asn Pro Arg Ala Gly Arg Ile Thr 325 330 335 Thr Val Asn Ser Gin Lys Ile Pro lie Leu Ser Set Leu Gin Leu Ser 340 345 350 Ala Glu Arg Gly Phe Leu Tyr Ser Asn Ala Ile Phe Ala Pro His Trp 355 360 365 Asn Ile Asn Ala Hit Asn Ala Leu Tyr Val Ile Arg Gly Asn Ala Arg 370 375 380 Ile Gln Val Val Asp His Lys Gly Asn Lys Val Phe Asp Asp Glu Val 385 390 395 400 Lys Gln Gly Gin Leu Ile Ile Val Pro Gin Tyr Phe Ala Val Ile Lys 405 410 415 Lys Ala Gly Asn Gln Gly Phe Glu Tyr Val Ala Phe Lys Thr Asn Asp 420 425 430 Asn Ala Met lie Asn Pro Leu Val Gly Arg Leu Ser Ala Phe A-g Ala 435 440 445 Ile Pro Glu Glu Val Leu Arg Ser Ser Phe Gln Ile Ser Ser Glu Glu 450 455 460 Ala Glu Glu Leu Lys Tyr Gly Arg Gln Glu Arg Leu Leu Leu Ser Glu 465 470 475 480 Gln Ser Gln Gln Gly Lys Lys Arg Ser Cys Leu Ser 485 490 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3477 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: double (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: promoter (B) LOCATION: 1..2509 (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: TTTAAAAGTT TGGTAGAAAA TTTGAGATAT TTGACGTCTA CGAGGCCAGA TATCAATTTG 60 CTGTTGGTGT GATTAACAAG TTTATGAAAA ATCCACGTCA GTCACATTTG TAGGCGGTTA 120 AGAAGATTTT GAAATATATT GAAAGTACTC ACAGTGTTGG CATTTTTTAT TCAGAAAATT 180 ATCCAGTTGA ATGGTTTGGC TACTGATAGT TATTGAGCAG GTGATACAAT AGAGAAGAAG 240 AGTACTTCAA GTTATGCATT TTTTATTGGT TCTGACGTAT TTTCCTCGAG TTCAAAGAAA 300 CAACAGGTGA TTGCATTGTT TACAGCAGAA GCAGAGTATA TTGCAGCGGC TAATAGTGCT 360 AATCAAGTTT TGTGGTTACG TTGCATGTTT GGTATTCTAC AATACAAGCA GGTTGATCTT 420 ACGAAAATTT ATTGTGATAG TAAGTCAGCT ATTGAATTGT CCAAGAATTT AGTACTTCAT 480 GGATGTAACA AGCATATTGG CATCAAATAT CACTTCACAC GTGAGTTGGT TCGAGAGAGA 540 GAGAGAGGTT GAAATTGATT ATTGCAGAAT TAAATAGTAA GTGGCTGACA TTTTCACCAA 600 GACATTGAAG ATAGAGATTT TTGTCAAGTT GAAGAATATG TTAGGCATGT CCAAGTTAGA 660 GGAGATTCGT TTAATGGAGG CAATATAGAA ACACAAACCA AGCCTTTATT ATTTGTTTAT 720 GCTGTCATGT GGGATTGGTA GTAGTATTGT TGGTTGGTAG GGTGGTCACA TGGGATTGAA 780 TTTCCTATGA CTAGTAGAGT TAGTAATAGA AGTTAGCCGC CAAGGGGTTT TGATGTGTAG 840 CTGTTGCGTC CGTCTTTTTT AGCCTTAAGA AGAAGTAGTC ACCTCCGTTG TGTTCTGCAT 900 GGTGTAGCAG AGCCTTGTTA TGATTAATAG AAAATTTTCC TTTGCCTCAA TATCGTTTTT 960 TTTTTTTATT GTTTCTGTGG GTTTTGTGTA TTTATCAATT TGGGTCCACC ACTTTTTCCA 1020 ACCATGATCT TAAGCATATC AGCTCACTTC CACTCTATTT CTTTACCATG ATTTTAAGTA 1080 CAATAATTTC CTAAAAAACC AAAAAAGAAT CATATCTATA AATTTTGAGA AAAGCATATA 1140 TACTGCTAAC ATGATTCTAC GTATAATAGT GGATTATTAA AAATTATTAA TTACATATTT 1200 TTGACATAAC CATCGGTGTA CCAAAAGCAC TAATGATTAC AACAGTAAAC ACGCAAAGTT 1260 GAGTAATTGA AACTGAAATT ACACATAGAC AAAAACTCAA CTAAACAATG TTAGAATGGA 1320 ATAGATTAGA GAACCATTGA ATGATCTAAC TCTGGAACTG GGGTTAAGAC AGTCTTCCCA 1380 AGCAACTTTT TTTGTCCATG ATTTGGCTAT CATATCACTA TCTTGAAATT TGTTCAGACA 1440 CACTGTGGGA GGCTGGAATC AATAGCTTGG ACTTGGATCA TTTATAGAAG CTGATGATCA 1500 TTATTGCTCA ACATATGAAT TTGATACAAA TGTCAGTGGA ATCAACTTCG TACTTTTTTT 1560 TTTTCCTCTT TTCTTTTGGA GTACAAGCCT ACCTACAAGG GGAAGGATAG AGGAAATGCA 1620 TAGAGGGAGA TTTAACCTCT ACCCAAGCGG CAGATACAAT GGGTCACGAT ACAGCTGGTT 1680 TATTGATGTA TTACAGCGGA AAACGATGTA GATGAGCAAC CTTTTCAAAG AACATAAGTC 1740 AAAATCATAG ATGTAAAGCA GTCAACTGAG TCTGTGGCAA TTGTTAGACG TAAAACTCTA 1800 TTCCATGTCA TTATTAGGTT TCTTGCTCTA TCTTTTAGTT TGATCCAACA TGGATTGGCT 1860 GTCTTTTGTT TGCTAATAAA GATTTTAAAT CATGGAATTT CCCTGTAGAA TGCCTTTAAT 1920 TACATGCCAC TAGACTAGAA ACGGTAATTG TTTAACAGAT ATTTATTCCA GGCATTGAAA 1980 TTATGAACTG CAACAGTCAT TTGCCTAGAA GTGTAAACCA ATTGTCTTCA ATAAAGGTGA 2040 ATAAAAATCG ATGAAGATAG ATAGGTGCTA GAAACTTAAA AGCAGAAGAT GATAGGTGTG 2100 ATGTAATACG CAGCAGTAGT GATCATCTTT CCATATCACA TCTTGAAAGA TCCCAAGATG 2160 AATGTGTGTT TGATTTGGGG TTTGATTCAT CAAAAGCCAT CGTAGCAGAT AATGCACCTT 2220 ACCATGCCAT TGCTAAAGTA CAAAAATTTC ATGCAAATAC AAACACAAAA GATTGAACAA 2280 TACATGTCAG AAACTCTATG CCACCAAGGC TTACACATCA TCTTTGGTGT AAAGAAGTGT 2340 TCATCTTCAT CAGCCATGCA CAAGACTGAG TAGCCAAGTG TAAAATGAAA ATTTTGACGT 2400 GTCGATTCCT CATCTTCCAT TACATGTTAT AAAAGGAGCC ATTTCCAAGC TCTAATCGCC 2460 GCATCCCCTC ACCACAAAAA CACACTACAC TCTCCTCTGT TGTCAGAGAA TGGCTCACTC 2520 TCATATGATT TCTCTTTCCT TGTACGTTCT TTTGTTCCTC GGCTGTTTGG CTCAACTAGG 2580 GAGACCACAG CCAAGGCTCA GGGGTAAAAC TCAGTGCGAT ATTCAGAAGC TTAATGCACA 2640 AGAACCATCC TTCAGGTTCC CATCAGAGGC TGGTTTAACT GAATTCTGGG ATTCTAATAA 2700 TCCAGAATTT GGGTGCGCTG GTGTGGAATT TGAGCGTAAC ACTGTCCAAC CTAAGGGCCT 2760 TCGTTTGCCT CATTACTCTA ACGTGCCTAA ATTCGTCTAC GTTGTCGAAG GCAGTTTCAT 2820 TTCCCATCCT TTCCATTATT TCTGGAGTTT TTTTTCTATT TTCTTCTTAA TCATCGTATT 2880 ATTCATTTTC TTCATGATTT AATCATTTTG GCATAATGCA GGTACCGGTG TTCAAGGCAC 2940 TGTGATCCCT GGTTGTGCTG AAACATTTGA ATCCCAGGGT GAATCATTTT GGGGTGGTCA 3000 GGAACAGCCG GGCAAAGGGC AAGAAGGCCA AGAGCAAGGT TCCAAAGGTG GTCAGGAAGG 3060 GCGAAGGCAA AGGTTTCCAG ACCGCCATCA GAAGCTCAGA AGGTTCCAAA AAGGAGATGT 3120 CCTTATATTG CTTCCTGGTT TCACTCAGTG GACATATAAT GATGGAGATG TTCCACTTGT 3180 CACTGTCACA CTTCTTGATG TTGCCAATGA CGTGAATCAG CTTGATTTGC AGTCCAGGGT 3240 AAGAAAACTT TCAATCCAAA CTTGCCAAGT ATTAATCAAA AAATAATCTC TTTCTGGGCA 3300 TATTTTATTG CGGTACCATC TTAATAAAAA AAAAATTTTA TACTTTCAGA AATTTTTCCT 3360 AGCCGGAAAC CCGCAACAGG GTGGTGGAAA GGAAGGCCAT CAAGGCCAGC AGCAGCAGCA 3420 TAGAAACATC TTCTCAGGAT TTGATGACCA CTTTTGGCTG ATGCTTTCAA TGTTGAC 3477 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "nucleotide" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: GCNGAYGTNT TYAAYCC 17 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: AAACATTGGC CTCCCCC 17 (2) INFORMATION FOR SEQ ID NO: 6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 19 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: CCAAACATCA AACTTCTCG 19 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: GAGAAATCAT ATGAGAGTGA GCC 23 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: TTCTTTTGTT CCTCGGCTGT TTG 23 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: GTGAGCCATT CTCTGAC (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 23 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: AGTTTGATCC AACATGGATT GGC 23 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 24 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION SEQ ID NO: 11: GCAAGAAACC TAATAATGAC ATGG 24 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 20 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: CCTCTTTTCT TTTGGAGTAC 20 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: CGCGGATCCG CG 12 (2) INFORMATION FOR SEQ ID NO: 14: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 33 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: CGCGGATCCG CGATGAGAGT GAGCCATTCT CTG 33 (2) INFORMATION FOR SEQ ID NO: 15: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 35 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: CGCGGATCCG CGCCTCTTTT CTTTTGGAGT ACAAG 35 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: CGCGGATCCG CGTAGGTTTC TTGCTCTATC TTTTAG 36 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: CGCGGATCCG CGGTGCTAGA AACTTAAAAG CAGAAG 36 (2) INFORMATION FOR SEQ ID NO: 18: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CGCGGATCCG CGACAAAAGA TTGAACAATA CATGTC 36 (2) INFORMATION FOR SEQ ID NO: 19: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19: TTTGATTTCA CGGGTTGGGG TTTCTACAGG 30 (2) INFORMATION FOR SEQ ID NO: 20: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE. DESCRIPTION: SEQ ID NO: 20: GGCTCGTATG TTGTGTGGAA TTGTGAGCGG 30 (2) INFORMATION FOR SEQ ID NO: 21: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: ATGTTACGTC CTGTAGAA 18 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 18 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: GCAAAGTCCC GCTAGTGC 18 (2) INFORMATION FOR SEQ ID NO: 23: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: CTGGATCGTT TCGCATG 17 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 16 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: CCAGAGTCCC GCTCAG 16 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 30 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: ACTAGGGGAT CCACAGCCAA GGCTCAGGGG 30 (2) INFORMATION FOR SEQ ID NO: 26: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 36 base pairs (B) TYPE: nucleotide (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: other nucleic acid (A) DESCRIPTION: /desc = "OLIGONUCLEOTIDE" (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 26: GTACTCTGCA GACATAATTA GCTCAAGCAA CTTCCC 36